First look: Princeton researchers peek into deepest recesses of human brainFebruary 29, 2008A team of scientists from Princeton University has devised a new experimental technique that produces some of the best functional images ever taken of the human brainstem, the most primitive area of the brain. The scientists believe they may be opening the door to inquiries into a region that acts as the staging area for the brain chemicals whose overabundance or absence in other parts of the brain are at the root of many neuropsychiatric disorders, like addiction, schizophrenia and Parkinson's disease. Reporting in the Feb. 28 edition of Science, the scientists describe using functional magnetic resonance imaging to study brainstem activity in dehydrated humans. The scanning technique allows researchers to watch the brain in action. The subjects were participating in classical conditioning experiments in which they were presented with a visual clue, then, at varying intervals, given a drink. The researchers were able to track changes in blood flow in areas of the brainstem associated with enhanced activity of the brain chemical dopamine -- as the person experienced either pleasure or disappointment at receiving or not receiving the reward. "For a long time, scientists have tried looking at this area of the brain and have been unsuccessful -- it's just too small," said Kimberlee D'Ardenne, the lead author on the paper. Until now, scientists wanting to use brain scans to study brain chemicals like dopamine were relegated to watching its effects in other more accessible parts of the brain, like the prefrontal cortex and ventral striatum. However, this was downstream of its source, and therefore possibly much less accurate, D'Ardenne said. "We wanted to try because the brainstem is so important to activities in the rest of the brain," said D'Ardenne, a doctoral student in the Department of Chemistry. "We believe it could be a key to understanding all kinds of important behavior." For the research, D'Ardenne collaborated with Jonathan Cohen, co-director of the Princeton Neuroscience Institute, and Samuel McClure and Leigh Nystrom, other institute scientists. They conducted the studies on the University's own brain scanner located on campus in Green Hall. Cohen noted that these findings provide a critical link between studies in non-human animals that have looked directly at the activity of dopamine cells in the brainstem and studies in humans of behaviors thought to be related to dopamine. "It could also open up entirely new avenues of study," he said. The team was able to develop high-resolution images that tracked the activity of tiny clusters of dopamine neurons. They weeded out distortions caused by many pulsing blood vessels in the brainstem. They also employed computerized rules of thumb known as algorithms and imaging techniques to reduce the effects of head movement and combine images from different subjects. The MRI device produces three-dimensional images that show what portions of the brain engage during actions and thought processes. This allows the investigators to correlate physical processes with mental activities with unprecedented precision. The brain stem, a tiny, root-shaped structure, is the lower part of the brain and sits atop the spinal cord. The area controls brain functions necessary for survival, such as breathing, digestion, heart rate, blood pressure and arousal. The brain structure also serves as the home base for the brain chemicals, also known as neuromodulators, such as dopamine, serotonin and norepinephrine. The chemicals spring forth into other brain regions from there, zipping along routes called axons. The team's experiments confirmed results already seen in animal studies. Blood flow increased in dopamine centers of the brainstem when test subjects were happily surprised with a reward. However, there was no activity when participants received less than what they expected, a finding that is different from the results of previous studies looking farther downstream. "We are just at the beginning of understanding these crucial pathways," D'Ardenne said. "But it gives us a hint about what is possible to know." The tiny clumps of cells containing neuromodulator chemicals in the brainstem, called nuclei, have long been known to play a critical role in the regulation of brain function, and disturbances of these systems have been implicated in most psychiatric disorders, from addiction to schizophrenia, D'Ardenne said. The Princeton group wants to understand how the brain's physical structures give rise to the functions of the mind, a field known as cognitive neuroscience. For years, neuroscientists focused on the brain while psychologists dealt with the mind. The new field combines both and is being powered by scientific advances in brain imaging and gene manipulation that allows researchers to record and measure the activity of brain cells as humans or animals perform mental tasks. Princeton University |
|||||||||||||||||||||
| Related Dopamine Current Events and Dopamine News Articles ISU researchers' findings bring hope for possible Parkinson's disease cure Researchers at Iowa State University have found an essential key to possibly cure Parkinson's disease and are looking for others. Widely used cholesterol-lowering drug may prevent progression Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease. Stress-induced changes in brain circuitry linked to cocaine relapse Stress-evoked changes in circuits that regulate serotonin in certain parts of the brain can precipitate a low mood and a relapse in cocaine-seeking, based on mouse studies published online this week in the Proceedings of the National Academy of Sciences. Researchers find brain cell transplants help repair neural damage A Swiss research team has found that using an animal's own brain cells (autologous transplant) to replace degenerated neurons in select brain areas of donor primates with simulated but asymptomatic Parkinson's disease and previously in a motor cortex lesion model, provides a degree of brain protection and may be useful in repairing brain lesions and restoring function. Changes in brain chemicals mark shifts in infant learning When do you first leave the nest? Early in development infants of many species experience important transitions-such as learning when to leave the protective presence of their mother to start exploring the wider world. Why antidepressants don't work for so many More than half the people who take antidepressants for depression never get relief. Cocaine exposure during pregnancy leads to impulsivity in male, not female, monkeys Adult male monkeys exposed to cocaine while in the womb have poor impulse control and may be more vulnerable to drug abuse than female monkeys, even a decade or more after the exposure, according to a new study by researchers at Wake Forest University School of Medicine. The findings could lead to a better understanding of human drug abuse. Scientists demonstrate link between genetic defect and brain changes in schizophrenia Researchers at the University of North Carolina at Chapel Hill School of Medicine have found that the 22q11 gene deletion - a mutation that confers the highest known genetic risk for schizophrenia - is associated with changes in the development of the brain that ultimately affect how its circuit elements are assembled. Fine-tuning treatments for depression New research clarifies how neurotransmitters like norepinephrine, serotonin, and dopamine, are regulated - a finding that may help fine-tune therapies for depression. Study supports possible role of urate in slowing Parkinson's disease progression By examining data from a 20-year-old clinical trial, a research team based at the MassGeneral Institute for Neurodegenerative Diseases (MGH-MIND) and Harvard School of Public Health (HSPH), has found evidence supporting the findings of their 2008 study - that elevated levels of the antioxidant urate may slow the progression of Parkinson's disease. More Dopamine Current Events and Dopamine News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||